Fjarde AP Fonden Fourth Swedish National Pension Fund Invests $5.09 Million in Astera Labs, Inc. $ALAB

Posted by Francis Steltz on Jun 9th, 2026

Fjarde AP Fonden Fourth Swedish National Pension Fund purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 30,600 shares of the company’s stock, valued at approximately $5,091,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. acquired a new position in shares of Astera Labs during the 4th quarter worth $18,708,000. Nordea Investment Management AB acquired a new position in shares of Astera Labs during the 4th quarter worth $2,028,000. Geneva Partners LLC acquired a new position in shares of Astera Labs during the 3rd quarter worth $1,876,000. Numerai GP LLC grew its stake in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares during the period. Finally, Swedbank AB grew its stake in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 28,737 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares of the company’s stock, valued at $945,868,091.84. This trade represents a 0.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,321,256 shares of company stock worth $480,893,146 over the last three months. Company insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Barclays raised their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. TD Cowen upped their price target on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price target on the stock. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Finally, Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

Read Our Latest Report on ALAB

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $346.33 on Tuesday. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $372.37. The company has a market capitalization of $59.36 billion, a PE ratio of 234.01, a price-to-earnings-growth ratio of 4.20 and a beta of 3.94. The firm’s 50-day moving average is $217.60 and its two-hundred day moving average is $173.27.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the company earned $0.33 EPS. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.